The net-zero target approval complements the company's near-term emission reduction targets
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
India has taken the lead in recognising NAFLD as a major non-communicable disease
Quinidine Sulphate helps manage rare irregular heartbeat conditions
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Subscribe To Our Newsletter & Stay Updated